2-[6-(2-cyano-6-isocyanophenyl)-9-dibenzofuran-2-ylcarbazol-3-yl]-3-isocyanobenzonitrile
C40H19N5O — CID 155645790
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[6-(2-cyano-6-isocyanophenyl)-9-dibenzofuran-2-ylcarbazol-3-yl]-3-isocyanobenzonitrile
2-[6-(2-cyano-6-isocyanophenyl)-9-dibenzofuran-2-ylcarbazol-3-yl]-3-isocyanobenzonitrile (PubChem CID 155645790) has the molecular formula C40H19N5O and a molecular weight of 585.63 g/mol. Its IUPAC name is 2-[6-(2-cyano-6-isocyanophenyl)-9-dibenzofuran-2-ylcarbazol-3-yl]-3-isocyanobenzonitrile.
Molecular Properties
| Compound Name | 2-[6-(2-cyano-6-isocyanophenyl)-9-dibenzofuran-2-ylcarbazol-3-yl]-3-isocyanobenzonitrile |
|---|---|
| PubChem CID | 155645790 |
| Molecular Formula | C40H19N5O |
| Molecular Weight | 585.63 g/mol |
| Exact Mass | 585.16 |
| IUPAC Name | 2-[6-(2-cyano-6-isocyanophenyl)-9-dibenzofuran-2-ylcarbazol-3-yl]-3-isocyanobenzonitrile |
| SMILES | [C-]#[N+]c1cccc(C#N)c1-c1ccc2c(c1)c1cc(-c3c(C#N)cccc3[N+]#[C-])ccc1n2-c1ccc2oc3ccccc3c2c1 |
| InChI | InChI=1S/C40H19N5O/c1-43-33-10-5-7-26(22-41)39(33)24-13-16-35-30(19-24)31-20-25(40-27(23-42)8-6-11-34(40)44-2)14-17-36(31)45(35)28-15-18-38-32(21-28)29-9-3-4-12-37(29)46-38/h3-21H |
| InChIKey | JIYYXOOLJYYWRL-UHFFFAOYSA-N |
| XLogP | 10.86 |
| TPSA | 74.37 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 46 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 585.63 |
| LogP ≤ 5 | 10.86 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155645790 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.